Position in ORGO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,110
+$77 QoQ
Shares Held
1,280
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#115
of 134 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $131,747,740 across 34 Drug Manufacturers - Specialty & Generic names. ORGO ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
158,184 | $85,708,836 | |
| 2 | ZTS |
Zoetis Inc.
|
112,370 | $8,074,908 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
288,888 | $7,109,533 | |
| 4 | VTRS |
Viatris Inc
|
411,537 | $6,535,207 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
30,217 | $5,092,773 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
59,330 | $2,804,529 | |
| 7 | LQDA |
Liquidia Corp
|
35,159 | $2,803,227 | |
| 8 | HLN |
Haleon plc
|
217,576 | $2,029,984 |
All Filings in ORGO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,110 | 1,280 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $3,033 | 1,280 | Shares | Defined | 2026-05-01 | |
| 2022-09-30 | $2,005 | 619 | Shares | Defined | 2022-10-25 | |
| 2022-03-31 | $3,688 | 484 | Shares | Defined | 2022-04-19 | |
| 2021-09-30 | $1,893 | 133 | Shares | Defined | 2021-10-15 | |
| No filing history on record for this holder in this stock. | ||||||